BEHIND THE SOFTWARE BLOG
Do you REALLY own your CTMS data?
As clinical research sites and site networks become more sophisticated, they’ve come to rely heavily on advanced CTMS, eRegulatory and
RealTime-CTMS Integrates with Numerous Systems for Max Performance!
These integrations combined with the RealTime-CTMS, they can help you take your clinical research performance to the next level.
Participant Engagement: It’s a Win-Win for Clinical Research and Study Participants
Sponsors, CROs, sites and clinical trial vendors work so very hard to make clinical trials successful. This arduous work includes
Did You Know RealTime-eDOCS Lite Comes FREE with a CTMS?
Our goal at RealTime-CTMS is to provide solutions that help make the research process simple and seamless. One of those
Maximize Growth And Profitability With These Powerful Metrics
Monitoring Key Performance Indicators (KPIs) is essential to ensuring the profitability and growth potential of your clinical research site.
How a Mobile App Improves Site Clinical Trial Performance
Does your CTMS system have a dedicated mobile app? If not, you may be asking, “Why would I even need a CTMS mobile app? My current CTMS vendor claims that it is not necessary because my CTMS scales to mobile devices.” Let’s dive into how RealTime, the only CTMS company to have a dedicated mobile app, is enabling clinical research coordinators, investigators, and other front-line researchers to execute their daily tasks more efficiently and effectively using tools that are only possible with a mobile app. The following are some of the key benefits that RealTime customers can enjoy by using the features on our MobileApp:
New Customer Feature Request Form Brings Ideas to Life
At RealTime, we are constantly investing in technology improvements to ensure customers get the most out of RealTime solutions. We
Pros and Cons of e-Signatures in Clinical Research
As the clinical research industry moves into an increasingly paperless, electronic world, all stakeholders involved in clinical trial processes are
